KLK3 and prostate cancer: Additionally, our in vivo studies have demonstrated that carnosol when given orally at a dose of 30 mg/kg inhibits the growth of prostate cancer in athymic nude mice by 36% along with a 26% decrease in serum prostate-specific antigen (PSA) levels compared to untreated control animals (Johnson et al., 2010).